Immuron IMRN
NASDAQ IMRN
$0.93 -0.04 (-4.02%)
As of: Oct 22, 2026 · 12:46 PM EDT

Immuron (IMRN) EBIT (2023 - 2024)

Updated

Immuron (IMRN) recorded EBIT of -$4.01 million in FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) EBIT (2023 - 2024) Analysis & Trends

Starting with FY2015, Immuron's EBIT history includes 12 fiscal years.

  • Annual EBIT has ranged from -$5.34 million in FY2025 to -$58,011 in FY2024 over the past five years.
  • Per Business Quant data, IMRN's EBIT was -$5.34 million in FY2025, -$58,011 in FY2024, -$2.02 million in FY2023 and -$1.89 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,169.76 Bn 1,138.35 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 648.06 Bn 567.92 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.37 Bn 476.48 Bn 12.70 Bn 6.43 Bn
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 303.45 Bn 267.44 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 269.03 Bn 242.72 Bn 12.86 Bn 3.16 Bn
7 Amgen 242.08 Bn 197.48 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn 4.27 Bn
10 Immuron 6.91 Mn -10.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.79 Mn
Sep 9, 2024 -38,654.88
Dec 31, 2023 -23,232.80
API Access

Immuron EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=IMRN&period=max&api_key=YOUR_API_KEY